Delivering global market access and Health Economics and Outcomes Research (HEOR) strategies and solutions
Global Value Communication, Evidence, and Modeling
Petauri Evidence partners with market access and HEOR teams across all global and local milestones, providing the strategy, insight, evidence, and tools to ensure commercial success.
We combine academic and technical rigor with specialized knowledge, creative flare, and commercial agility in an evidence-driven approach to optimize patient access to medicines and technologies.
Our Expertise
Global Market Access and Pricing
Develop pricing and launch strategies that maximize commercial potential
Our global strategists determine optimal pricing and the best route to market for your product.
With our global payer network and deep understanding of key launch markets, we provide evidence, payer insights, analysis, and recommendations to inform each stage of your market access journey.
Local Access and HTA
Secure national and regional reimbursement with expert partners for each stage of the HTA journey
We offer a full health technology assessment (HTA) service from early strategy development through to evidence generation, dossier writing, and post-submission support.
By applying experience within and as external assessors for UK HTA bodies, we help pharma, medical device, and diagnostic manufacturers successfully navigate NICE, SMC, and AWMSG in the UK; NCPE in Ireland; CDA – AMC in Canada; PBAC in Australia; and the EU JCA.
Health Economics and Statistics
Evaluate and demonstrate economic value to deliver the evidence that drives access
With deep technical expertise across our HEOR team, we develop, evaluate, and provide training on all types of health economic modeling and statistics to support reimbursement and access.
This includes early-stage models and data analysis to support internal decision-making; cost-effectiveness, cost-consequence, and budget impact models; and network meta-analysis and indirect treatment analysis for HTA, reimbursement, and payer engagement.
Evidence Strategy and Synthesis
Build a comprehensive evidence base that drives strategic decision-making
We strategize and synthesize the clinical and economic evidence required by global payers and reimbursement bodies to evaluate treatments.
From gold-standard systematic literature reviews to rapid/targeted reviews, we select the right methods to support your needs and those of your audiences.
Value Communication
Engage decision-makers with evidence-driven value propositions
Working with global and local market access teams, we develop value communication materials that combine consistent, impactful, evidence-based messages with tailored uptake scenarios.
Our market access experts collaborate with our in-house digital development and design teams to create customer-facing tools that empower field teams and drive uptake.
Our Leadership
David Niziol
President, Petauri Evidence
Anthony Hatswell
Chief Scientific Officer
Anthony Bentley
Director, Commercial Modeling
Adam Brown
Director, Global Pricing and Market Access
Andy Buckland
Director, Medical Writing
Ash Bullement
Director, HEOR
Simone Critchlow
Director, HEOR
Clare Foy
Director, Global Pricing and Market Access
Samantha Gillard
Director, HTA
Shona Lang
Director, Systematic Review
Hannah Palin
Director, Local Market Access
Andrew Spencer
Director, Digital
Jodie Worrall
Director, Systematic Review
The Latest From Petauri
Expert Insights, Industry News, and Upcoming Events